Detalhe da pesquisa
1.
Interleukin-17 contributes to Ross River virus-induced arthritis and myositis.
PLoS Pathog
; 18(2): e1010185, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143591
2.
Characterizing the acute antibody response of monkeypox and MVA-BN vaccine following an Australian outbreak.
J Med Virol
; 96(1): e29407, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240403
3.
The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022: a cross-sectional serosurvey.
Med J Aust
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38815982
4.
New Detection of Locally Acquired Japanese Encephalitis Virus Using Clinical Metagenomics, New South Wales, Australia.
Emerg Infect Dis
; 29(3): 627-630, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36823673
5.
Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020.
Med J Aust
; 214(4): 179-185, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538019
6.
Basic insights into Zika virus infection of neuroglial and brain endothelial cells.
J Gen Virol
; 101(6): 622-634, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32375993
7.
RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.
PLoS Pathog
; 13(2): e1006155, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28207896
8.
Abalone Hemocyanin Blocks the Entry of Herpes Simplex Virus 1 into Cells: a Potential New Antiviral Strategy.
Antimicrob Agents Chemother
; 60(2): 1003-12, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26643336
9.
Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection.
J Virol
; 89(1): 581-93, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25339772
10.
Inhibition of Interleukin 1ß Signaling by Anakinra Ameliorates Proinflammatory Cytokine Responses in Zika Virus-Infected Human Blood-Brain Barrier Endothelial Cells.
J Infect Dis
; 220(9): 1539-1540, 2019 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31116849
11.
Mannose binding lectin is required for alphavirus-induced arthritis/myositis.
PLoS Pathog
; 8(3): e1002586, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22457620
12.
Seroprevalence of Japanese encephalitis virus-specific antibodies in Australia following novel epidemic spread: protocol for a national cross-sectional study.
BMJ Open
; 14(2): e075569, 2024 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326269
13.
Enhancement of Zika Infection by Dengue Virus-Specific Antibody Is Associated With Low Levels of Antiviral Factors.
J Infect Dis
; 216(5): 612-614, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28931226
14.
SARS-CoV-2 Seroprevalence in a Cohort of International Travellers Returning to Rural Australia: Enablers and Barriers to Containment of COVID-19.
Aust N Z J Public Health
; 47(1): 100003, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680916
15.
Immunofluorescent Antibody Techniques in the Diagnosis of SARS-CoV-2 Infection in Humans.
Methods Mol Biol
; 2452: 99-107, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35554903
16.
Emergence of Japanese encephalitis in Australia: a diagnostic perspective.
Pathology
; 54(6): 669-677, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35995617
17.
Emerging Genotype IV Japanese Encephalitis Virus Outbreak in New South Wales, Australia.
Viruses
; 14(9)2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146660
18.
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine.
Viruses
; 14(9)2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146829
19.
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance.
Nat Commun
; 13(1): 2745, 2022 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585202
20.
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey.
Open Forum Infect Dis
; 9(3): ofac002, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35169588